Font Size

Local News

E-mail

Close Window E-mail This Page

Genentech Forms Committee To Consider Roche Bid

Required fields are marked with an asterisk(*)

Recipient E-mail:*
- Your Name:*
- Your E-mail:*
Add a Message:
Send me a copy of this e-mail.

Type the characters in this picture:*

Click here to refresh with new letters

The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

Send E-mail

Print Share + Comments

Jul 24, 2008 5:42 pm US/Pacific

Genentech Forms Committee To Consider Roche Bid

SOUTH SAN FRANCISCO (AP) ―

Click to enlarge 1 of 1: Genentech headquarters in South San Francisco.
AP

Close

numSlides of totalImages

Genentech Inc. says the company has officially formed a special committee consisting of its three independent board members to consider Roche Holding's takeover bid.

Committee chairman Charles Sanders said in a statement Thursday that there was "no assurance" the committee would approve a deal with Roche.

Sanders called the Roche offer Monday of $89 per share for the 44 percent of Genentech stock not owned by the Swiss pharmaceutical maker "unsolicited and unexpected."

Many Wall Street analysts have called Roche's offer far too low. Other analysts have said Genentech's partnership agreement with Roche gives the Basel, Switzerland-based company significant leverage to keep the price down.

Genentech said in its statement that it had no obligation to agree to any deal with Roche.